Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | MAPK13 | O15264 | 8/20 | 0.44 |
| ▸ | GCGR | P47871 | 8/20 | 0.44 |
| ▸ | MAPK12 | P53778 | 8/20 | 0.44 |
| ▸ | MAPK11 | Q15759 | 8/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 8/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.42 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.42 |
| ▸ | FRK | P42685 | 2/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.42 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.42 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.42 |
| ▸ | GSK3B | P49841 | 2/20 | 0.42 |
| ▸ | PTK6 | Q13882 | 2/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.42 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13115431 | 0.86 | CYP11B1 (0.50) | CYP11B1ALDH1A1PKMMAPK13GCGR | |
| SCHEMBL13232351 | 0.86 | MAPK13 (0.52) | ALDH1A1MAPK13GCGRMAPK12MAPK11 | |
| SCHEMBL13115449 | 0.86 | CYP11B2 (0.51) | CYP11B1MAPK13GCGRMAPK12MAPK11 | |
| SCHEMBL13115452 | 0.84 | NPC1 (0.46) | CYP11B1ALDH1A1PKMCYP19A1NPY5R | |
| SCHEMBL13115406 | 0.84 | CYP11B1 (0.48) | CYP11B1ALDH1A1PKMMAPK13GCGR | |
| SCHEMBL13115464 | 0.83 | CYP11B1 (0.47) | CYP11B1ALDH1A1PKMMAPK13GCGR | |
| SCHEMBL13115479 | 0.81 | CYP11B1 (0.45) | CYP11B1ALDH1A1PKMMAPK13GCGR | |
| SCHEMBL7365631 | 0.79 | CYP11B1 (0.53) | CYP11B1ALDH1A1PKMMAPK13GCGR | |
| SCHEMBL13115445 | 0.77 | MAPK13 (0.42) | ALDH1A1MAPK13GCGRMAPK12MAPK11 | |
| SCHEMBL13263305 | 0.74 | NPY5R (0.48) | CYP11B1ALDH1A1MAPK13GCGRMAPK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100256165-A1 | LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER | HONGU MITSUYA | 2010-10-07 | — | — | US | disclosed |
| US-20100256165-A1 | LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER | HONGU MITSUYA | 2010-10-07 | — | — | US | disclosed |
| US-7759373-B2 | Large conductance calcium-activated K channel opener | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
| US-7759373-B2 | Large conductance calcium-activated K channel opener | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256165-A1 | LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER | KCNN3, KCNN2, KCNN1 | CYP11B1 4021/4885ALDH1A1 4600/4885PKM 1434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.